Crossmark

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy

Published Online: 2021-01-07

Published Print: 2021-06

Authors

Ge, Yongpeng https://orcid.org/0000-0003-3674-9307
Li, Shanshan

Tian, Xiaolan

He, Linrong

Lu, Xin

Wang, Guochun
License Information

Text and Data Mining valid from 2021-01-07

Version of Record valid from 2021-01-07
More Information

Article History

Received: 20 May 2020

Revised: 11 November 2020

Accepted: 29 November 2020

First Online: 7 January 2021

Compliance with ethical standards

:

: None.

Document is current